Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer ; volume:8 ; number:1 ; day:23 ; month:11 ; year:2018 ; pages:1-9 ; date:12.2018
Scientific reports ; 8, Heft 1 (23.11.2018), 1-9, 12.2018
- Urheber
-
Thaper, Daksh
Vahid, Sepideh
Kaur, Ramandeep
Kumar, Sahil
Nouruzi, Shaghayegh
Bishop, Jennifer L.
Johansson, Martin
Zoubeidi, Amina
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-35612-z
- URN
-
urn:nbn:de:101:1-2019010302341329940866
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Thaper, Daksh
- Vahid, Sepideh
- Kaur, Ramandeep
- Kumar, Sahil
- Nouruzi, Shaghayegh
- Bishop, Jennifer L.
- Johansson, Martin
- Zoubeidi, Amina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Chrysoeriol suppresses hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes and inhibits JAK2/STAT3 signaling
Metformin inhibits melanoma cell metastasis by suppressing the miR-5100/SPINK5/STAT3 axis
Enzalutamide inhibits PEX10 function and sensitizes prostate cancer cells to ROS activators
MiR-618 suppresses the proliferation, invasion, and migration of non-small lung cancer via the JAK2/STAT3 axis
Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
Flavokawain C inhibits glucose metabolism and tumor angiogenesis in nasopharyngeal carcinoma by targeting the HSP90B1/STAT3/HK2 signaling axis
Clinical Pharmacokinetic Studies of Enzalutamide
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
Correction: Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia
Osthole inhibits triple negative breast cancer cells by suppressing STAT3
Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway
Chrysoeriol suppresses hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes and inhibits JAK2/STAT3 signaling
Metformin inhibits melanoma cell metastasis by suppressing the miR-5100/SPINK5/STAT3 axis
Enzalutamide inhibits PEX10 function and sensitizes prostate cancer cells to ROS activators
MiR-618 suppresses the proliferation, invasion, and migration of non-small lung cancer via the JAK2/STAT3 axis
Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
Flavokawain C inhibits glucose metabolism and tumor angiogenesis in nasopharyngeal carcinoma by targeting the HSP90B1/STAT3/HK2 signaling axis
Clinical Pharmacokinetic Studies of Enzalutamide
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
Correction: Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia
Osthole inhibits triple negative breast cancer cells by suppressing STAT3
Bufalin suppresses tumour microenvironment-mediated angiogenesis by inhibiting the STAT3 signalling pathway
Chrysoeriol suppresses hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes and inhibits JAK2/STAT3 signaling
Metformin inhibits melanoma cell metastasis by suppressing the miR-5100/SPINK5/STAT3 axis
Enzalutamide inhibits PEX10 function and sensitizes prostate cancer cells to ROS activators
MiR-618 suppresses the proliferation, invasion, and migration of non-small lung cancer via the JAK2/STAT3 axis
Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
Flavokawain C inhibits glucose metabolism and tumor angiogenesis in nasopharyngeal carcinoma by targeting the HSP90B1/STAT3/HK2 signaling axis
Clinical Pharmacokinetic Studies of Enzalutamide
LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling
Correction: Targeting STAT3 by a small molecule suppresses pancreatic cancer progression
Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia
Osthole inhibits triple negative breast cancer cells by suppressing STAT3